. Author manuscript; available in PMC: 2016 Aug 1.

Published in final edited form as: Inflamm Bowel Dis. 2015 Aug;21(8):1976–1981. doi: 10.1097/MIB.0000000000000386

Table 1.

Characteristics of included studies

Study ID	Year	N	PO formulation	IV formulation	Follow-up	Design
Erichsen	2005	19	Fe fumarate	sucrose	2 weeks	RCT, cross-over
Kulnigg	2008	200	FeSO4	carboxymaltose	3mths	RCT
Lindgren	2009	91	FeSO4	sucrose	20 weeks	RCT
Reinisch	2013	338	FeSO4	isomaltoside	8 weeks	RCT
Schroder	2005	46	FeSO4	sucrose	6 weeks	RCT